Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Aug. 31, 2025	Aug. 31, 2024
Cash flows from operating activities:
Net income	$ 327,268	$ 464,413
Adjustments to reconcile net income to net cash provided by operating activities:
Equity in income of unconsolidated joint ventures	(18,447)	(22,654)
Distributions of earnings from unconsolidated joint ventures	27,741	21,275
Amortization of debt issuance costs	2,686	2,602
Depreciation and amortization	27,440	28,259
Deferred income taxes	0	5,700
Gain on sale of investment	0	(12,516)
Stock-based compensation	25,131	25,252
Inventory impairments and land option contract abandonments	18,351	3,685
Changes in assets and liabilities:
Receivables	7,166	6,205
Inventories	(330,019)	(504,436)
Accounts payable, accrued expenses and other liabilities	(63,835)	(14,405)
Other, net	8,358	(3,299)
Net cash provided by operating activities	31,840	81
Cash flows from investing activities:
Contributions to unconsolidated joint ventures	(10,593)	(12,611)
Return of investments in unconsolidated joint ventures	2,965	1,992
Proceeds from sale of investment	0	1,709
Purchases of property and equipment, net	(34,609)	(29,228)
Net cash used in investing activities	(42,237)	(38,138)
Cash flows from financing activities:
Borrowings under revolving credit facility	555,000	0
Repayments under revolving credit facility	(305,000)	0
Payments on mortgages and land contracts due to land sellers and other loans	0	(2,822)
Issuance of common stock under employee stock plans	652	9,272
Stock repurchases	(438,460)	(250,000)
Tax payments associated with stock-based compensation awards	(15,884)	(16,505)
Payments of cash dividends	(52,806)	(53,537)
Net cash used in financing activities	(256,498)	(313,592)
Net decrease in cash and cash equivalents	(266,895)	(351,649)
Cash and cash equivalents at beginning of period	599,193	727,342
Cash and cash equivalents at end of period	$ 332,298	$ 375,693